EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates

Magdy Abdelhamid iD, Mostafa M Abdrabou iD, Emanuel Faris, Sameh El Kafas iD, Mohamed Hosny, Ahmed Hassan iD

Cardiac Failure Review · 03.11.2025 · 11

DOI: 10.15420/cfr.2025.17 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 03.11.2025. Verfasst von Magdy Abdelhamid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Faculty of Medicine, Kasr Al Ainy - Cairo University Cairo, Egypt. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), established treatments for type 2 diabetes and obesity, exhibit cardiovascular benefits extending to heart failure (HF) with preserved ejection fraction (HFpEF). Mechanisms contributing to HF improvement include significant weight loss, blood pressure reduction, enhanced glycaemic control, anti-inflammatory effects and potential direct cardioprotective and vascular actions. Although cardiovascular outcome trials provided initial positive signals, dedicated HFpEF trials confirmed the efficacy of GLP-1RAs in HFpEF patients with obesity and/or diabetes. In some trials, GLP-1RAs significantly improved weight, symptoms of HF and HF events. Current evidence strongly supports GLP-1RAs in patients with HFpEF and obesity, with or without type 2 diabetes. The data do not support their use solely for HF with reduced ejection fraction.

Schlagwörter

Stichwörter der Autor:innen

6-minute walk distanceGlucagon-like peptide-1 receptor agonistsheart failure with preserved ejection fractionmajor adverse cardiovascular eventsobesitytype 2 diabetes

Autor:innen und Institutionen

  • Department of Cardiology, Faculty of Medicine, Kasr Al Ainy - Cairo University Cairo, Egypt.

ORCID-Profile: Magdy Abdelhamid, Mostafa M Abdrabou, Sameh El Kafas, Ahmed Hassan

Zitieren

APA

Abdelhamid, M., Abdrabou, M. M., Faris, E., El Kafas, S., Hosny, M., & Hassan, A. (2025). Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates. Cardiac Failure Review, 11. https://doi.org/10.15420/cfr.2025.17

Vancouver

Abdelhamid M, Abdrabou MM, Faris E, El Kafas S, Hosny M, Hassan A. Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates. Cardiac Failure Review. 2025;11. doi:10.15420/cfr.2025.17

BibTeX
@article{Abdelhamid2025,
  author = {Abdelhamid, Magdy and Abdrabou, Mostafa M and Faris, Emanuel and El Kafas, Sameh and Hosny, Mohamed and Hassan, Ahmed},
  title = {Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates},
  journal = {Cardiac Failure Review},
  year = {2025},
  volume = {11},
  doi = {10.15420/cfr.2025.17}
}
Kostenlos starten →